Tag: China

United BioPharma begin to build a new biopharmaceutical manufacturing plant

United BioPharma (UBP), a Chinese clinical stage biotech company, announced the beginning of construction of a state-of-the-art biopharmaceutical manufacturing plant in China.

China established a new drug regulator

china street
After about five years as a standalone agency, the China Food and Drug Administration (CFDA) will merge into a gigantic national market supervision administration, with drug regulation as a new, second-tier bureau underneath.

Chinese biotech appears as a significant player in CAR-T therapy field

gene therapy
GenScript’s shares have risen more than sixfold since June, when it reported positive results from early studies in 35 patients with a type of blood cancer.

Merck KGaA and Schneider Electric sign a Memorandum of Understanding

merck kgaa
Merck and Schneider Electric, a global specialist in energy management, announced the signing of a Memorandum of Understanding that aims to automate biopharmaceutical processes for China’s biopharmaceutical industry.

ShanghaiTech University and Jing Medicine starts a research collaboration

good laboratory practice
ShanghaiTech University and Jing Medicine Technology Ltd. announced an over $100 million strategic collaboration to discover and develop novel small molecule anti-cancer drugs

Clover Biopharmaceuticals will use FlexFactory biomanufacturing platform

Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, has chosen General Electric Healthcare’s FlexFactory, a biomanufacturing platform

TLC and Jixi Biotechnology formed a joint venture

TLC announced that it has signed an agreement with Jixi Biotechnology to form a joint venture with the purpose to conduct clinical studies, register, and commercialize TLC’s pipeline

GlaxoSmithKline launches its HIV drug in China

British pharmaceutical giant GlaxoSmithKline has officially launched its blockbuster triple-therapy HIV drug in China, pricing it lower than in neighboring markets

Wuxi Griffin will give effect to Western GMP standards in its operation

pharmaceutical manufacturing
The new company, Wuxi Griffin, is to operate as an international contract manufacturer of sterile fill pharmaceuticals. It is a western managed joint venture between Sweden and China

Mundipharma will distribute Grünenthal’s analgesic in China

Grünenthal and Mundipharma announced today that they have entered into a License and Distribution Agreement. Under its terms, Mundipharma will market and distribute Grünenthal’s Tramal® in China

Japanese company Eisai expands its capacity in China

Eisai Co. Ltd., announced today that its Chinese subsidiary, Eisai China Inc. has completed construction of a new oral solid dose production facility

Merus entered into strategic collaboration with Simcere Pharmaceutical Group

test tube
Merus and Simcere Pharmaceutical Group announced that Merus has agreed to grant an exclusive license to develop and commercialize three bispecific antibodies

Vericel starts the cooperation with Innovative Cellular Therapeutics

laboratory test
Vericel Corporation announced the initiation of its License Agreement with Innovative Cellular Therapeutics

WuXi Biologics put its new cGMP manufacturing facility into service

WuXi Biologicsannounced that its cGMP biologics manufacturing facility in Wuxi city with 30000 L bioreactor capacity entered into full operation

Johnson & Johnson launches its innovation hub in China

johnson & johnson
Johnson & Johnson Innovation announced a collaboration with the Shanghai Municipal Government and Shanghai Pharma Engine Company Ltd

STA Pharmaceutical sees rapid growth in MAH programs in China

STA Pharmaceutical reports that it has seen a rapid uptake in companies with intent to market their products in China